Lobera T, Navarro B, Del Pozo M D, González I, Blasco A, Escudero R, Venturini M, Alarcón E
Department of Allergy, Hospital San Pedro/San Millán, Logroño, Spain.
J Investig Allergol Clin Immunol. 2009;19(1):57-60.
Although rare, anaphylactic reactions induced by proton pump inhibitors have been reported. The presence of cross-reactivity between different members of the group is not clear. We studied 9 patients with adverse reactions to omeprazole. Clinical symptoms appeared immediately in 8 patients and after 4 hours in 1. Symptoms ranged from urticaria/angioedema in 7 cases to anaphylaxis in 2 cases. Skin prick tests and oral controlled challenge tests with omeprazole, lansoprazole, and pantoprazole were performed. Skin prick or intradermal tests with omeprazole were positive in 8 patients. Four were also positive to pantoprazole. Prick tests with lansoprazole were always negative. Lansoprazole was administered to all 9 patients, with good tolerance in 8. Only 3 patients were challenged with pantoprazole and developed widespread urticaria. We present 9 patients with immunoglobulin E-mediated allergy to omeprazole. In most of our cases, lansoprazole proved to be a good alternative treatment.
尽管罕见,但已有质子泵抑制剂诱发过敏反应的报道。该类药物不同成员之间是否存在交叉反应尚不清楚。我们研究了9例对奥美拉唑有不良反应的患者。8例患者的临床症状立即出现,1例在4小时后出现。症状从7例荨麻疹/血管性水肿到2例过敏反应不等。对患者进行了用奥美拉唑、兰索拉唑和泮托拉唑的皮肤点刺试验及口服激发试验。8例患者用奥美拉唑进行皮肤点刺或皮内试验呈阳性。其中4例对泮托拉唑也呈阳性。用兰索拉唑进行点刺试验均为阴性。对所有9例患者给予兰索拉唑治疗,8例耐受性良好。仅3例患者用泮托拉唑激发试验后出现广泛荨麻疹。我们报告了9例对奥美拉唑有免疫球蛋白E介导过敏反应的患者。在我们的大多数病例中,兰索拉唑被证明是一种很好的替代治疗药物。